Cancer Development Current Events | Cancer Development News | 2
|
| Page
2 of
106 |
2104 Results |
|
|
|
Sort By:
Page Views | Date |
Molecular pathway linked to breast cancer recurrence
A study published in the September issue of Cancer Cell provides new evidence for a genetic pathway that is involved in the recurrence of breast cancer and identifies a potential target for development of new anticancer therapeutics. view more (2005-09-20)
Cancer Research UK supports additional TroVax phase II trial in colorectal cancer
Oxford BioMedica announced today that Cancer Research UK (CRUK) has agreed to conduct and sponsor an open label Phase II trial with Oxford BioMedica's leading cancer immunotherapy product, TroVax®, in colorectal cancer patients who have liver metastases. The decision by CRUK follows extensive review of the successful Phase I/II data of TroVax... view more... (2003-08-28)
Breast cancer etiology may vary by subtype
Women's reproductive and lifestyle characteristics can be linked to different invasive breast cancer subtypes. Data on 2544 breast cancer cases, presented in the open access journal Breast Cancer Research, suggests that traditional risk factors for development of the condition are associated with different kinds of tumor. view more (2009-05-22)
Ovarian cancer stem cells identified, characterized
Researchers at Yale School of Medicine have identified, characterized and cloned ovarian cancer stem cells and have shown that these stem cells may be the source of ovarian cancer's recurrence and its resistance to chemotherapy. view more (2008-04-18)
Potential dangers of long term tamoxifen use
Tamoxifen prolongs the life of women with breast cancer and may significantly reduce the risk of developing the disease in those with an inherited tendency. But, suggests a leading article in the Journal of Clinical Pathology, long term use may produce other serious abnormalities, including cancer. view more (1999-02-12)
Morphochem And Fox Chase Cancer Center Enter Into Collaboration To Develop Novel Treatments For Cancer
Morphochem AG, a leader in chemical genomics, and Fox Chase Cancer Center (Philadelphia, US), a comprehensive cancer center, have entered into a research collaboration that will leverage the strengths of both organizations to develop new treatments for cancer. The collaboration is wide ranging and provides for multiple research projects under the... view more... (2002-10-16)
New developments in biomarkers for epithelial ovarian cancer
With the genomic revolution radical improvement has been made in methods of detection of ovarian cancer. view more (2007-11-30)
Dietary fat itself not likely to cause breast cancer
A diet high in fat is not by itself likely to cause breast cancer, suggests a study in the Journal of Epidemiology and Community Health. But it is likely to deplete the body of an essential nutrient, a factor that is probably responsible for most cases of the disease, concludes the research. The author examined all the relevant epidemiological and... view more... (2000-10-16)
atugen AG and metaGen Pharmaceuticals Sign Target Validation Agreement
Berlin, Germany, February 11, 2003 - atugen AG and metaGen Pharmaceuticals GmbH announced today that they have signed an agreement to evaluate the application of atugen's target validation technology in research and development of metaGen's novel cancer drug targets. Under the terms of the agreement atugen will select and screen specially designed... view more... (2003-02-11)
Who gets cancer treatment, and who completes it?
Cancer treatment is now very effective in many cases, yet not all patients with cancer are referred and not all complete their treatment programme. This has puzzled cancer specialists who have wondered if psychological factors might influence their decision and has led to research carried out by Dr Stan Lindsay from the Institute of Psychiatry in... view more... (2002-11-13)
Tummy troubles -- gastrin key in bacterial-induced stomach cancer
Current research suggests that levels of gastrin play a key role in the development of Helicobacter-induced stomach cancer. view more (2009-06-24)
Research reveals molecular pathway behind invasive prostate cancers
University of Cincinnati (UC) cancer and cell biologists have identified a new molecular pathway key to the development of invasive prostate cancers. view more (2009-05-19)
Food - Can It Really Prevent Cancer?
Food is a major and underused anticancer weapon, according to the All-Party Parliamentary Group on Cancer. In collaboration with the Institute of Food Research, the Group is calling for diet to be better deployed in reducing cancer risk in the UK. "With dietary interventions, we have the potential to prevent around a third of all... view more... (2003-10-21)
New role for gene that counteracts formation of tumors
The researchers, connected to Ghent University, have discovered the function of an important mediator involved in suppressing the development of tumors. view more (2005-08-26)
Deakin University research finds rogue cells that could cause spread of breast cancer
Stephanie Lebret completed the study for her PhD at Deakin's Centre for Cellular and Molecular Biology under the supervision of Associate Professor Leigh Ackland. view more (2007-06-14)
Canadian research breakthrough holds promise for development of effective cancer therapies
Researchers Dr. Marc Therrien at the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal, and Dr. Frank Sicheri, at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital in Toronto, have discovered a new target that may be instrumental in the development of new, more effective cancer... view more... (2009-09-03)
Glypican-3 gene function in regulating body size helps inform novel cancer treatments
In a leading study that has implications for the development of novel therapies for a number of breast, lung and ovarian cancers that have lost the expression of a gene called glypican-3 (GPC3), Sunnybrook researchers have discovered how the loss of the GPC3 gene induces overgrowth through certain growth factors such as Sonic Hedgehog which... view more... (2008-05-13)
Burnham Researchers Turn Cancer Friend into Cancer Foe
Burnham Institute for Medical Research today announced that scientists have created a peptide that binds to Bcl-2, a protein that protects cancer cells from programmed cell death, and converts it into a cancer cell killer. view more (2008-10-08)
Scientists are developing markers capable of spotting minute numbers of cancer cells in blood
Scientists have identified three molecular markers which, when used together, are capable of detecting minute amounts of metastatic cancer cells in the blood of patients. Although this research is in its early days, they hope it will lead to the development of a simple and easy test to spot cancer cells that are spreading from the original tumour.... view more... (2002-03-21)
New research findings may enable earlier diagnosis of uterine cancer
Cancer is a genetic disease. It occurs when changes take place in the genes that regulate cell division, cell growth, cell death, cell signalling and blood vessel formation - either due to mutations caused by external factors such as smoking or radiation - or due to inherited changes. view more (2009-01-28)
|
|
| Page
2 of
106 |
2104 Results |
|
|
|
Sort By:
Page Views | Date |
|
